Inhibition of H-ras as a treatment for experimental brain C6 glioma

Molecular Brain Research

Volumn 111, Issue 1-2, 2003, Pages 42-51

  Perkins, Eddie ^a   Calvert, John ^a   Lancon, John A ^a   Parent, Andrew D ^a   Zhang, John ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

C6 glioma; Diallyl disulfide; H ras; Intracerebral tumors; Oncogene

Indexed keywords

DIALLYL DISULFIDE; SOYBEAN OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CORPUS STRIATUM; GENE CONTROL; GENE EXPRESSION; GLIOMA; IMPLANTATION; LIFESPAN; MALE; MENTAL HEALTH; MOLECULAR BIOLOGY; NONHUMAN; ONCOGENE H RAS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RAT; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR CELL; TUMOR VOLUME;

ANIMALIA; GLYCINE MAX;

EID: 0037451086     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00668-X     Document Type: Article

References (45)

1. Ames B.N., Gold L.S., Willett W.C. The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA. 92:1995;5258-5265.
2. Avgeropoulos N.G., Batchelor T.T. New treatment strategies for malignant gliomas. Oncologist. 4:1999;209-224.
3. Azizi S.A., Miyamoto C. Principles of treatment of malignant gliomas in adults: an overview. J. Neurovirol. 4:1998;204-216.
4. Barbacid M. Involvement of ras oncogenes in the initiation of carcinogen-induced tumors. Princess Takamatsu Symp. 17:1986;43-53.
5. Barbacid M. ras genes. Annu. Rev. Biochem. 56:1987;779-827.
6. Barbacid M. ras oncogenes: their role in neoplasia. Eur. J. Clin. Invest. 20:1990;225-235.
7. Bardeesy N., Bastian B.C., Hezel A., Pinkel D., DePinho R.A., Chin L. Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol. Cell Biol. 21:2001;2144-2153.
8. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
9. Benda P., Someda K., Messer J., Sweet W.H. Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture. J. Neurosurg. 34:1971;310-323.
10. Benda P., Lightbody J., Sato G., Levine L., Sweet W. Differentiated rat glial cell strain in tissue culture. Science. 161:1968;370-371.
11. Bernsen H.J., van der Kogel A.J. Antiangiogenic therapy in brain tumor models. J. Neurooncol. 45:1999;247-255.
12. Bertram K.J., Shipley M.T., Ennis M., Sanberg P.R., Norman A.B. Permeability of the blood-brain barrier within rat intrastriatal transplants assessed by simultaneous systemic injection of horseradish peroxidase and Evans blue dye. Exp. Neurol. 127:1994;245-252.
13. Beutler A.S., Banck M.S., Wedekind D., Hedrich H.J. Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model. Hum. Gene Ther. 10:1999;95-101.
14. Bollag G., McCormick F. Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature. 351:1991;576-579.
15. Bollag G., Adler F., elMasry N., McCabe P.C., Conner E. Jr., Thompson P., McCormick F., Shannon K. Biochemical characterization of a novel KRAS insertion mutation from a human leukemia. J. Biol. Chem. 271:1996;32491-32494.
16. Chin L. Modeling malignant melanoma in mice: pathogenesis and maintenance. Oncogene. 18:1999;5304-5310.
17. Chin L., Tam A., Pomerantz J., Wong M., Holash J., Bardeesy N., Shen Q., O'Hagan R., Pantginis J., Zhou H., Horner J.W., Cordon-Cardo C., Yancopoulos G.D., DePinho R.A. Essential role for oncogenic Ras in tumour maintenance. Nature. 400:1999;468-472.
18. Croteau D., Mikkelsen T., Rempel S.A., Bogler O., Rosenblum M. New innovations and developments for glioma treatment. Clin. Neurosurg. 48:2001;60-81.
19. Ellis C., Moran M., McCormick F., Pawson T. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature. 343:1990;377-381.
20. Goya L., Feng P.T., Aliabadi S., Timiras P.S. Effect of growth factors on the in vitro growth and differentiation of early and late passage C6 glioma cells. Int. J. Dev. Neurosci. 14:1996;409-417.
21. Haubruck H., McCormick F. Ras p21: effects and regulation. Biochim. Biophys. Acta. 1072:1991;215-229.
22. Karpati G., Li H., Nalbantoglu J. Molecular therapy for glioblastoma. Curr. Opin. Mol. Ther. 1:1999;545-552.
23. Katz M.E., McCormick F. Signal transduction from multiple Ras effectors. Curr. Opin. Genet. Dev. 7:1997;75-79.
24. Kirsch M., Santarius T., Black P.M., Schackert G. Therapeutic anti-angiogenesis for malignant brain tumors. Onkologie. 24:2001;423-430.
25. Kumar R., Sukumar S., Barbacid M. Activation of ras oncogenes preceding the onset of neoplasia. Science. 248:1990;1101-1104.
26. Kun L.E. Brain tumors. Challenges and directions. Pediatr. Clin. North Am. 44:1997;907-917.
27. Maltese W.A., Defendini R., Green R.A., Sheridan K.M., Donley D.K. Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Clin. Invest. 76:1985;1748-1754.
28. McCabe P.C., Haubruck H., Polakis P., McCormick F., Innis M.A. Functional interaction between p21rap1A and components of the budding pathway in Saccharomyces cerevisiae. Mol. Cell Biol. 12:1992;4084-4092.
29. McCormick F. Signal transduction. How receptors turn Ras on. Nature. 363:1993;15-16.
30. McCormick F. Ras biology in atomic detail. Nat. Struct. Biol. 3:1996;653-655.
31. McCormick F. Signalling networks that cause cancer. Trends Cell Biol. 9:1999;M53-M56.
32. Nagano N., Sasaki H., Aoyagi M., Hirakawa K. Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol. (Berl.). 86:1993;117-125.
33. Pulciani S., Santos E., Long L.K., Sorrentino V., Barbacid M. ras gene amplification and malignant transformation. Mol. Cell Biol. 5:1985;2836-2841.
34. Qiu R.G., Chen J., McCormick F., Symons M. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA. 92:1995;11781-11785.
35. Qiu R.G., Chen J., Kirn D., McCormick F., Symons M. An essential role for Rac in Ras transformation. Nature. 374:1995;457-459.
36. Raila F.A., Bowles A.P. Jr., Perkins E., Terrell A. Sequential imaging and volumetric analysis of an intracerebral C6 glioma by means of a clinical MRI system. J. Neurooncol. 43:1999;11-17.
37. Santarius T., Kirsch M., Rossi M.L., Black P.M. Molecular aspects of neuro-oncology. Clin. Neurol. Neurosurg. 99:1997;184-195.
38. Singh S.V. Impact of garlic organosulfides on p21(H-ras) processing. J. Nutr. 131:2001;1046S-1048S.
39. Singh S.V., Mohan R.R., Agarwal R., Benson P.J., Hu X., Rudy M.A., Xia H., Katoh A., Srivastava S.K., Mukhtar H., Gupta V., Zaren H.A. Novel anti-carcinogenic activity of an organosulfide from garlic: inhibition of H-RAS oncogene transformed tumor growth in vivo by diallyl disulfide is associated with inhibition of p21H-ras processing. Biochem. Biophys. Res. Commun. 225:1996;660-665.
40. Spaargaren M., Bischoff J.R., McCormick F. Signal transduction by Ras-like GTPases: a potential target for anticancer drugs. Gene Expr. 4:1995;345-356.
41. Sparnins V.L., Barany G., Wattenberg L.W. Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis. 9:1988;131-134.
42. Wasson J.C., Saylors R.L. III, Zeltzer P., Friedman H.S., Bigner S.H., Burger P.C., Bigner D.D., Look A.T., Douglass E.C., Brodeur G.M. Oncogene amplification in pediatric brain tumors. Cancer Res. 50:1990;2987-2990.
43. Wattenberg L.W., Sparnins V.L., Barany G. Inhibition of N-nitrosodiethylamine carcinogenesis in mice by naturally occurring organosulfur compounds and monoterpenes. Cancer Res. 49:1989;2689-2692.
44. Yang F.C., Merlino G., Chin L. Genetic dissection of melanoma pathways in the mouse. Semin. Cancer Biol. 11:2001;261-268.
45. You M.J., Castrillon D.H., Bastian B.C., O'Hagan R.C., Bosenberg M.W., Parsons R., Chin L., DePinho R.A. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc. Natl. Acad. Sci. USA. 99:2002;1455-1460.